– Cutting-edge spatial omics technologies to map cancer cells and their immune environment in high resolution, allowing AI to unlock potential for new breakthrough treatments – – Landmark research project is 100x larger than existing efforts – – Data will be generated from thousands of patients across multiple cancers – – University of Pittsburgh, Gustave […]
MOSAIC is a landmark $50 million project to revolutionize cancer research through the use of spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors. Collaborating with Gustave Roussy, the University of Pittsburgh through the UPMC Hillman Cancer Center, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, Charité – Universitätsmedizin Berlin, NanoString Technologies and other providers of analytical instrumentation and assays for spatial biology, Owkin will invest $50 million to build MOSAIC.
